Fed Regist. 1998 Jan 14;63(9):2245-8.
The Food and Drug Administration (FDA) is announcing the new fees the agency will assess for inspections of mammography facilities starting on February 13, 1998. The Mammography Quality Standards Act of 1992 (the MQSA) requires FDA to assess and collect fees from mammography facilities to cover the costs of annual inspections required by the MQSA. Because these costs have increased since inspections began in 1995, FDA is raising the fees accordingly. This notice explains which facilities are subject to payment of inspection fees, provides information on the costs included in developing inspection fees, and provides information on the inspection, billing, and collection processes. This is the first increase in inspection fees under the MQSA since the initial fee was established in 1995.
美国食品药品监督管理局（FDA）宣布，自1998年2月13日起，该机构将对乳房X线摄影设施检查收取新费用。1992年的《乳房X线摄影质量标准法案》（MQSA）要求FDA向乳房X线摄影设施评估并收取费用，以支付MQSA要求的年度检查费用。由于自1995年开始检查以来这些成本有所增加，FDA相应提高了费用。本通知解释了哪些设施需支付检查费用，提供了制定检查费用所包含成本的信息，并提供了有关检查、计费和收款流程的信息。这是自1995年设定初始费用以来，MQSA下检查费用的首次上调。
